Longevity Technology
@LongevityTech
Daily news and insights on research, investments and technologies that extend life and improve the quality of that extended life. #Longevity#
加入 December 2018
2.3K 正在关注 19K 粉丝
Mission Therapeutics has begun a 36-patient Phase 1b study of MTX325, a drug aimed at clearing out damaged mitochondria in the brain.
#longevity# #geroscience# #MissionTherapeutics# #MTX325# #mitochondria#
显示更多
